Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Frequency Therapeutics to Present at Upcoming Investor Conferences


Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced that Chief Executive Officer David L. Lucchino will present at the following investor conferences:

A webcast of the presentations may be accessed on the investors section of Frequency's website, investors.frequencytx.com. A replay of each presentation will be posted to the Frequency website following the event.

About Frequency Therapeutics

Frequency Therapeutics is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The Company's progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. The Company's lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing function. FX-322 is being evaluated in multiple ongoing clinical studies in patients with sensorineural hearing loss. The Company also is evaluating additional diseases where its PCA approach could create functional tissue, including in a pre-clinical program in multiple sclerosis.

Headquartered in Lexington, Mass., Frequency has an ex-U.S. license and collaboration agreement with Astellas Pharma Inc. for FX-322, as well as additional collaboration and licensing agreements with academic and nonprofit research organizations including Massachusetts Eye and Ear, Mass General Brigham, the Massachusetts Institute of Technology, The Scripps Research Institute and Cambridge Enterprises Limited. For more information, visit www.frequencytx.com and follow Frequency on Twitter @Frequencytx.


These press releases may also interest you

at 09:15
Wipro Appoints Vinay Firake as Chief Executive Officer for APMEA Strategic Market Unit
Wipro Limited , a leading technology services and consulting company, today announced the appointment of Vinay Firake as the Chief Executive Officer, APMEA (Asia Pacific, India, Middle East & Africa) Strategic Market Unit (SMU), effective...

at 09:08
Tim Holley Joins MyFitnessPal as Chief Product Officer
MyFitnessPal, the #1 global nutrition and food tracking app, today announced that it has appointed Tim Holley as Chief Product Officer. In this role, Tim will apply his extensive experience driving sustained growth through reliable delivery of...

at 09:05
Dexian on Mission to Expand Government Solutions Business
Dexian, a leading provider of staffing, IT, and workforce solutions, today announced that it is on a mission to expand its Government Solutions business. The company has appointed Mike Zembrzuski, a seasoned expert in the federal market, as Chief...

at 09:05
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system?the Swoop® system?today announced it has entered into agreements with...

at 09:05
Earnest Names Nick Norcross as Chief Product Officer
Earnest, a fintech company empowering students to maximize their financial futures, announced Nick Norcross as its new Chief Product Officer. Norcross brings nearly two decades of successful fintech product development and leadership to the team....

at 09:05
R.H. Seale to Transition to Chairman Emeritus
Q2 Holdings, Inc. , a leading provider of digital transformation solutions for financial services, today announced that Chairman R.H. "Hank" Seale III will not stand for re-election to Q2's board of directors at the end of his current term, which...

More news about Science and technology...


News published on and distributed by: